Search

Characterization of visible abnormalities in patients with Barrett's esophagus (BE) can be challenging, especially for inexperienced endoscopists. This results in suboptimal diagnostic accuracy and poor interobserver agreement. Computer-aided diagnosis (CADx) systems may assist endoscopists. We aimed to develop, validate, and benchmark a CADx system for BE neoplasia. The CADx system received pretraining with ImageNet and then consecutive domain-specific pretraining with GastroNet, which includes 5 million endoscopic images. It was subsequently trained and internally validated using 1758 narrow-band imaging (NBI) images of early BE neoplasia (352 patients) and 1838 NBI images of nondysplastic BE (173 patients) from 8 international centers. CADx was tested prospectively on corresponding image and video test sets with 30 cases (20 patients) of BE neoplasia and 60 cases (31 patients) of nondysplastic BE. The test set was benchmarked by 44 general endoscopists in 2 phases (phase 1, no CADx assistance; phase 2, with CADx assistance). Ten international BE experts provided additional benchmark performance. Stand-alone sensitivity and specificity of the CADx system were 100% and 98% for images and 93% and 96% for videos, respectively. CADx outperformed general endoscopists without CADx assistance in terms of sensitivity (P =.04). Sensitivity and specificity of general endoscopists increased from 84% to 96% and 90% to 98% with CAD assistance (P <.001). CADx assistance increased endoscopists' confidence in characterization (P <.001). CADx performance was similar to that of the BE experts. CADx assistance significantly increased characterization performance of BE neoplasia by general endoscopists to the level of expert endoscopists. The use of this CADx system may thereby improve daily Barrett surveillance. [ABSTRACT FROM AUTHOR]

Simple Summary: Advanced endoscopy techniques that generate microscopic images can be used to optimize cancer screening in patients with an increased risk of oesophageal cancer. However, these microscopic endoscopy images are highly detailed and difficult for doctors to interpret. Support by artificial intelligence (AI) could be useful when the image is too complex for human interpretation. Therefore, this study investigated whether AI as second assessor can assist doctors in assessing complex, microscopic endoscopy images for the presence of oesophageal cancer. To investigate this, we developed online training and testing modules for doctors to learn to classify these novel images, and to assess the potential of AI assistance in analysing the oesophageal microscopy images. Our data showed that the best diagnostic scores for cancer recognition emerged through the collaboration between doctors and AI as the second assessor. Therefore, AI could be used to support the clinical implementation of endoscopy techniques that generate microscopic images. Optical biopsy in Barrett's oesophagus (BE) using endocytoscopy (EC) could optimize endoscopic screening. However, the identification of dysplasia is challenging due to the complex interpretation of the highly detailed images. Therefore, we assessed whether using artificial intelligence (AI) as second assessor could help gastroenterologists in interpreting endocytoscopic BE images. First, we prospectively videotaped 52 BE patients with EC. Then we trained and tested the AI pm distinct datasets drawn from 83,277 frames, developed an endocytoscopic BE classification system, and designed online training and testing modules. We invited two successive cohorts for these online modules: 10 endoscopists to validate the classification system and 12 gastroenterologists to evaluate AI as second assessor by providing six of them with the option to request AI assistance. Training the endoscopists in the classification system established an improved sensitivity of 90.0% (+32.67%, p < 0.001) and an accuracy of 77.67% (+13.0%, p = 0.020) compared with the baseline. However, these values deteriorated at follow-up (−16.67%, p < 0.001 and -8.0%, p = 0.009). Contrastingly, AI-assisted gastroenterologists maintained high sensitivity and accuracy at follow-up, subsequently outperforming the unassisted gastroenterologists (+20.0%, p = 0.025 and +12.22%, p = 0.05). Thus, best diagnostic scores for the identification of dysplasia emerged through human–machine collaboration between trained gastroenterologists with AI as the second assessor. Therefore, AI could support clinical implementation of optical biopsies through EC. [ABSTRACT FROM AUTHOR]

This pilot study evaluated the performance of a recently developed computer-aided detection (CADe) system for Barrett's neoplasia during live endoscopic procedures. Fifteen patients with a visible lesion and 15 without were included in this study. A CAD-assisted workflow was used that included a slow pullback video recording of the entire Barrett's segment with live CADe assistance, followed by CADe-assisted level-based video recordings every 2 cm of the Barrett's segment. Outcomes were per-patient and per-level diagnostic accuracy of the CAD-assisted workflow, in which the primary outcome was per-patient in vivo CADe sensitivity. In the per-patient analyses, the CADe system detected all visible lesions (sensitivity 100%). Per-patient CADe specificity was 53%. Per-level sensitivity and specificity of the CADe-assisted workflow were 100% and 73%, respectively. In this pilot study, detection by the CADe system of all potentially neoplastic lesions in Barrett's esophagus was comparable to that of an expert endoscopist. Continued refinement of the system may improve specificity. External validation in larger multicenter studies is planned. (Clinical trial registration number: NCT05628441.) [ABSTRACT FROM AUTHOR]

The endoscopic evaluation of narrow-band imaging (NBI) zoom imagery in Barrett's esophagus (BE) is associated with suboptimal diagnostic accuracy and poor interobserver agreement. Computer-aided diagnosis (CAD) systems may assist endoscopists in the characterization of Barrett's mucosa. Our aim was to demonstrate the feasibility of a deep-learning CAD system for tissue characterization of NBI zoom imagery in BE. The CAD system was first trained using 494,364 endoscopic images of general endoscopic imagery. Next, 690 neoplastic BE and 557 nondysplastic BE (NDBE) white-light endoscopy overview images were used for refinement training. Subsequently, a third dataset of 112 neoplastic and 71 NDBE NBI zoom images with histologic correlation was used for training and internal validation. Finally, the CAD system was further trained and validated with a fourth, histologically confirmed dataset of 59 neoplastic and 98 NDBE NBI zoom videos. Performance was evaluated using fourfold cross-validation. The primary outcome was the diagnostic performance of the CAD system for classification of neoplasia in NBI zoom videos. The CAD system demonstrated accuracy, sensitivity, and specificity for detection of BE neoplasia using NBI zoom images of 84%, 88%, and 78%, respectively. In total, 30,021 individual video frames were analyzed by the CAD system. Accuracy, sensitivity, and specificity of the video-based CAD system were 83% (95% confidence interval [CI], 78%-89%), 85% (95% CI, 76%-94%), and 83% (95% CI, 76%-90%), respectively. The mean assessment speed was 38 frames per second. We have demonstrated promising diagnostic accuracy of predicting the presence/absence of Barrett's neoplasia on histologically confirmed unaltered NBI zoom videos with fast corresponding assessment time. [ABSTRACT FROM AUTHOR]

In medical imaging, a proper gold-standard ground truth as, e.g., annotated segmentations by assessors or experts is lacking or only scarcely available and suffers from large intervariability in those segmentations. Most state-of-the-art segmentation models do not take inter-observer variability into account and are fully deterministic in nature. In this work, we propose hypersphere encoder–decoder networks in combination with dynamic leaky ReLUs, as a new method to explicitly incorporate inter-observer variability into a segmentation model. With this model, we can then generate multiple proposals based on the inter-observer agreement. As a result, the output segmentations of the proposed model can be tuned to typical margins inherent to the ambiguity in the data. For experimental validation, we provide a proof of concept on a toy data set as well as show improved segmentation results on two medical data sets. The proposed method has several advantages over current state-of-the-art segmentation models such as interpretability in the uncertainty of segmentation borders. Experiments with a medical localization problem show that it offers improved biopsy localizations, which are on average 12% closer to the optimal biopsy location. [ABSTRACT FROM AUTHOR]

Featured Application: This work focuses on the use of deep learning and convolutional neural networks to classify dysplasia in patients with Barrett's Esophagus. For this, we use the Narrow Band Imaging modality, which exploits different wavelengths to capture the tissue at different levels of penetration depth, leading to high-contrast imaging of mucosal and vascular patterns. Such patterns reveal information on histology, but they are hard to interpret for physicians. Our approach will aid the endoscopist in the interpretation of NBI imagery, leading to a higher false positive detections and a more robust diagnosis. In addition, this work also shows the potential benefits of using endoscopy-driven pretraining, instead of the more commonly used natural-image pretraining based on e.g., ImageNet. Endoscopic diagnosis of early neoplasia in Barrett's Esophagus is generally a two-step process of primary detection in overview, followed by detailed inspection of any visible abnormalities using Narrow Band Imaging (NBI). However, endoscopists struggle with evaluating NBI-zoom imagery of subtle abnormalities. In this work, we propose the first results of a deep learning system for the characterization of NBI-zoom imagery of Barrett's Esophagus with an accuracy, sensitivity, and specificity of 83.6%, 83.1%, and 84.0%, respectively. We also show that endoscopy-driven pretraining outperforms two models, one without pretraining as well as a model with ImageNet initialization. The final model outperforms absence of pretraining by approximately 10% and the performance is 2% higher in terms of accuracy compared to ImageNet pretraining. Furthermore, the practical deployment of our model is not hampered by ImageNet licensing, thereby paving the way for clinical application. [ABSTRACT FROM AUTHOR]

Early Barrett's neoplasia are often missed due to subtle visual features and inexperience of the non-expert endoscopist with such lesions. While promising results have been reported on the automated detection of this type of early cancer in still endoscopic images, video-based detection using the temporal domain is still open. The temporally stable nature of video data in endoscopic examinations enables to develop a framework that can diagnose the imaged tissue class over time, thereby yielding a more robust and improved model for spatial predictions. We show that the introduction of Recurrent Neural Network nodes offers a more stable and accurate model for tissue classification, compared to classification on individual images. We have developed a customized Resnet18 feature extractor with four types of classifiers: Fully Connected (FC), Fully Connected with an averaging filter (FC Avg (n = 5)), Long Short Term Memory (LSTM) and a Gated Recurrent Unit (GRU). Experimental results are based on 82 pullback videos of the esophagus with 46 high-grade dysplasia patients. Our results demonstrate that the LSTM classifier outperforms the FC, FC Avg (n = 5) and GRU classifier with an average accuracy of 85.9% compared to 82.2%, 83.0% and 85.6%, respectively. The benefit of our novel implementation for endoscopic tissue classification is the inclusion of spatio-temporal information for improved and robust decision making, and it is the first step towards full temporal learning of esophageal cancer detection in endoscopic video. [ABSTRACT FROM AUTHOR]

We aimed to develop and validate a deep-learning computer-aided detection (CAD) system, suitable for use in real time in clinical practice, to improve endoscopic detection of early neoplasia in patients with Barrett's esophagus (BE). We developed a hybrid ResNet-UNet model CAD system using 5 independent endoscopy data sets. We performed pretraining using 494,364 labeled endoscopic images collected from all intestinal segments. Then, we used 1704 unique esophageal high-resolution images of rigorously confirmed early-stage neoplasia in BE and nondysplastic BE, derived from 669 patients. System performance was assessed by using data sets 4 and 5. Data set 5 was also scored by 53 general endoscopists with a wide range of experience from 4 countries to benchmark CAD system performance. Coupled with histopathology findings, scoring of images that contained early-stage neoplasia in data sets 2–5 were delineated in detail for neoplasm position and extent by multiple experts whose evaluations served as the ground truth for segmentation. The CAD system classified images as containing neoplasms or nondysplastic BE with 89% accuracy, 90% sensitivity, and 88% specificity (data set 4, 80 patients and images). In data set 5 (80 patients and images) values for the CAD system vs those of the general endoscopists were 88% vs 73% accuracy, 93% vs 72% sensitivity, and 83% vs 74% specificity. The CAD system achieved higher accuracy than any of the individual 53 nonexpert endoscopists, with comparable delineation performance. CAD delineations of the area of neoplasm overlapped with those from the BE experts in all detected neoplasia in data sets 4 and 5. The CAD system identified the optimal site for biopsy of detected neoplasia in 97% and 92% of cases (data sets 4 and 5, respectively). We developed, validated, and benchmarked a deep-learning computer-aided system for primary detection of neoplasia in patients with BE. The system detected neoplasia with high accuracy and near-perfect delineation performance. The Netherlands National Trials Registry, Number: NTR7072 [ABSTRACT FROM AUTHOR]

Introduction: Endoscopic detection of early neoplasia in Barrett's esophagus is difficult. Computer Aided Detection (CADe) systems may assist in neoplasia detection. The aim of this study was to report the first steps in the development of a CADe system for Barrett's neoplasia and to evaluate its performance when compared with endoscopists., Methods: This CADe system was developed by a consortium, consisting of the Amsterdam University Medical Center, Eindhoven University of Technology, and 15 international hospitals. After pretraining, the system was trained and validated using 1.713 neoplastic (564 patients) and 2.707 non-dysplastic Barrett's esophagus (NDBE; 665 patients) images. Neoplastic lesions were delineated by 14 experts. The performance of the CADe system was tested on three independent test sets. Test set 1 (50 neoplastic and 150 NDBE images) contained subtle neoplastic lesions representing challenging cases and was benchmarked by 52 general endoscopists. Test set 2 (50 neoplastic and 50 NDBE images) contained a heterogeneous case-mix of neoplastic lesions, representing distribution in clinical practice. Test set 3 (50 neoplastic and 150 NDBE images) contained prospectively collected imagery. The main outcome was correct classification of the images in terms of sensitivity., Results: The sensitivity of the CADe system on test set 1 was 84%. For general endoscopists, sensitivity was 63%, corresponding to a neoplasia miss-rate of one-third of neoplastic lesions and a potential relative increase in neoplasia detection of 33% for CADe-assisted detection. The sensitivity of the CADe system on test sets 2 and 3 was 100% and 88%, respectively. The specificity of the CADe system varied for the three test sets between 64% and 66%., Conclusion: This study describes the first steps towards the establishment of an unprecedented data infrastructure for using machine learning to improve the endoscopic detection of Barrett's neoplasia. The CADe system detected neoplasia reliably and outperformed a large group of endoscopists in terms of sensitivity., (© 2023 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.)